We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Siemens to Close Fast Track Diagnostics Business

By LabMedica International staff writers
Posted on 19 Mar 2024

Siemens Healthineers (Erlangen, Germany) has announced its intention to close its Fast Track Diagnostics unit, a small collection of polymerase chain reaction (PCR) testing products that is part of the Diagnostics business. This product portfolio is sold mainly in the European market. The demand for the Fast Track Diagnostics portfolio has declined significantly since the peak of the COVID-19 pandemic.

Siemens offers in vitro diagnostic test solutions for almost every clinical environment. Its central laboratory analyzers are utilized in research laboratories, clinical laboratories of local community hospitals, independent specialty laboratories, and in the world’s largest reference labs. The company’s point-of-care testing solutions support care everywhere from remote pop-up health clinics to community physician offices, and outpatient care facilities to patients’ bedsides in hospital units.


Image: The Fast Track Diagnostics unit, a small collection of PCR testing products, is part of Siemens’ Diagnostics business (Photo courtesy of Siemens)
Image: The Fast Track Diagnostics unit, a small collection of PCR testing products, is part of Siemens’ Diagnostics business (Photo courtesy of Siemens)

Siemens has differentiated its in vitro diagnostic test offerings with flexible, scalable, and integrated automation capabilities that improve control over laboratory testing and operational workflows. Fast Track Diagnostics is a minor player in the molecular diagnostics space and represents a very small part of the overall revenue of Siemens’ Diagnostics business. Siemens intends to close the Fast Track Diagnostics unit by September 2024.

Related Links:
Siemens Healthineers 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Latest Industry News

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis

Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership